Conversely, only 17% (4 of 23) of the MYCN- non-amplified/favorable histology neuroblastomas showed focal or negative expression of PTEN, whereas 82% (14 of 17) of the ones with MYCN-amplified/unfavorable histology had this limited PTEN expression (Table 2). The gene discussed is MYCN; the disease is neuroblastoma.